There were 919 press releases posted in the last 24 hours and 167,871 in the last 365 days.

Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019

/EIN News/ -- BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31st Annual ROTH Conference March 19, 2019. The Conference is taking place March 17th - March 19th, 2019 at the Ritz Carlton Laguna Niguel, California.

Jason Grenfell-Gardner, Chief Executive Officer of Teligent, Inc., will present on Tuesday March 19th at 1:30 p.m. PT. 

The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com 

Teligent.jpg


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.